Eva Dombi

25PUBLICATIONS
133CO-AUTHORS
Neurology and neuromuscular diseasesGene and molecular therapyNeonatologyPeripheral nervous systemMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 13, 2026
Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic Target.

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Dec 31, 2025
Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysis.

Johannes Salamon, Brigitte C Widemann, Andrea M Gross

|Sep 24, 2025
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas.

Niousha Ahmari, Kwangmin Choi, Jianqiang Wu

|Jul 25, 2025
Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm.

Ayo Adeyemi, Andrea M Gross, Andrea Baldwin

|Mar 19, 2025
Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas.

Eva Dombi, Andrea M Gross, Brigitte C Widemann

Pageof 5

Frequent Collaborators

12 joint publications

Brigitte Widemann

10 joint publications

Andrea M Gross

6 joint publications

AeRang Kim

6 joint publications

John Shern